These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26406890)

  • 21. Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake.
    Thors L; Eriksson J; Fowler CJ
    Br J Pharmacol; 2007 Nov; 152(5):744-50. PubMed ID: 17676056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
    Lam FF; Luk PW; Ng ES
    Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
    Okine BN; Norris LM; Woodhams S; Burston J; Patel A; Alexander SP; Barrett DA; Kendall DA; Bennett AJ; Chapman V
    Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assay of FAAH Activity.
    Bari M; Feole M; Maccarrone M
    Methods Mol Biol; 2016; 1412():131-6. PubMed ID: 27245899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
    Hoyer FF; Khoury M; Slomka H; Kebschull M; Lerner R; Lutz B; Schott H; Lütjohann D; Wojtalla A; Becker A; Zimmer A; Nickenig G
    J Mol Cell Cardiol; 2014 Jan; 66():126-32. PubMed ID: 24286707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models.
    Caprioli A; Coccurello R; Rapino C; Di Serio S; Di Tommaso M; Vertechy M; Vacca V; Battista N; Pavone F; Maccarrone M; Borsini F
    J Pharmacol Exp Ther; 2012 Jul; 342(1):188-95. PubMed ID: 22514334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
    Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
    Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of diuresis and natriuresis by renomedullary infusion of a dual inhibitor of fatty acid amide hydrolase and monoacylglycerol lipase.
    Ahmad A; Daneva Z; Li G; Dempsey SK; Li N; Poklis JL; Lichtman A; Li PL; Ritter JK
    Am J Physiol Renal Physiol; 2017 Nov; 313(5):F1068-F1076. PubMed ID: 28768662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH.
    Holt S; Fowler CJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):237-44. PubMed ID: 12644895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anandamide deficiency and heightened neuropathic pain in aged mice.
    Bishay P; Häussler A; Lim HY; Oertel B; Galve-Roperh I; Ferreirós N; Tegeder I
    Neuropharmacology; 2013 Aug; 71():204-15. PubMed ID: 23597506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy.
    Uhelski ML; Khasabova IA; Simone DA
    J Neurophysiol; 2015 Mar; 113(5):1501-10. PubMed ID: 25505113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells.
    Winkler K; Ramer R; Dithmer S; Ivanov I; Merkord J; Hinz B
    Oncotarget; 2016 Mar; 7(12):15047-64. PubMed ID: 26930716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
    Justinova Z; Mangieri RA; Bortolato M; Chefer SI; Mukhin AG; Clapper JR; King AR; Redhi GH; Yasar S; Piomelli D; Goldberg SR
    Biol Psychiatry; 2008 Dec; 64(11):930-7. PubMed ID: 18814866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of anandamide and activation of the endocannabinoid system.
    Lowin T; Zhu W; Dettmer-Wilde K; Straub RH
    Arthritis Rheum; 2012 Dec; 64(12):3867-76. PubMed ID: 22933357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase-2 mediates anandamide metabolism in the mouse brain.
    Glaser ST; Kaczocha M
    J Pharmacol Exp Ther; 2010 Nov; 335(2):380-8. PubMed ID: 20702753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen.
    Fowler CJ; Janson U; Johnson RM; Wahlström G; Stenström A; Norström K; Tiger G
    Arch Biochem Biophys; 1999 Feb; 362(2):191-6. PubMed ID: 9989926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive cyclooxygenase-1 and induced cyclooxygenase-2 in isolated human iris inhibited by S(+) flurbiprofen.
    van Haeringen NJ; van Sorge AA; Carballosa Coré-Bodelier VM
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):353-61. PubMed ID: 10977131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.
    Celorrio M; Fernández-Suárez D; Rojo-Bustamante E; Echeverry-Alzate V; Ramírez MJ; Hillard CJ; López-Moreno JA; Maldonado R; Oyarzábal J; Franco R; Aymerich MS
    Brain Behav Immun; 2016 Oct; 57():94-105. PubMed ID: 27318096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways.
    Bradshaw HB; Rimmerman N; Hu SS; Benton VM; Stuart JM; Masuda K; Cravatt BF; O'Dell DK; Walker JM
    BMC Biochem; 2009 May; 10():14. PubMed ID: 19460156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.